JENNIFER RAMIREZ: Open Payments
NPI 1023484201 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 13 payments from 10 companies in 2025. Trend: 2023 $160 · 2024 $121 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $42 |
| Brainsway USA INC | 1 | $39 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $29 |
| Alkermes, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: REXULTI, AUSTEDO XR, VRAYLAR, Deep TMS System, Quviviq, VIVITROL, COBENFY, FANAPT.
Industry payments across AZ — which companies pay providers there.
